Morphic Holding Inc (MORF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MORF | BMY | AMGN | GILD | VRTX |
| Company | Morphic Holding Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 28.41 | 49.16 | 272.14 | 67.09 | 404.00 |
| High | 29.59 | 49.47 | 274.48 | 67.68 | 406.86 |
| Low | 28.25 | 48.96 | 271.05 | 67.06 | 403.47 |
| Last | 28.76 | 49.06 | 273.49 | 67.11 | 404.67 |
| Change | +0.26 | -0.08 | +1.58 | +0.16 | +4.75 |
| % Change | +0.91% | -0.16% | +0.58% | +0.24% | +1.19% |
| Volume | 362,506 | 5,743,496 | 1,568,736 | 2,984,896 | 554,305 |
| 20-Day Average Volume | 394,079 | 10,747,961 | 2,165,095 | 6,213,188 | 948,569 |
| Previous Close | 28.50 | 49.14 | 271.91 | 66.95 | 399.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 30.37 | 50.55 | 272.00 | 69.35 | 404.22 |
| 20-Day Raw Stochastic | 23.82% | 21.06% | 47.34% | 18.00% | 48.88% |
| 20-Day Relative Strength | 42.26% | 42.01% | 49.02% | 34.52% | 48.69% |
| Weighted Alpha | -11.54 | -25.60 | +11.64 | -20.36 | +18.13 |
| Today's Opinion | 56% Sell | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 72% Sell | 88% Sell | 40% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 8% Sell | 24% Sell | 8% Buy | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.60% since 04/16/24 | +1.66% since 04/16/24 | +3.10% since 04/16/24 | +0.04% since 04/16/24 | +2.97% since 04/16/24 |
| Low | 27.12 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 29.59 on 04/23/24 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -12.36% since 03/22/24 | -5.53% since 03/22/24 | -0.83% since 03/22/24 | -7.26% since 03/22/24 | -2.35% since 03/22/24 |
| Low | 27.12 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 35.56 on 04/01/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +4.63% since 01/23/24 | -2.11% since 01/23/24 | -11.63% since 01/23/24 | -15.28% since 01/23/24 | -7.69% since 01/23/24 |
| Low | 27.12 on 04/19/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 41.47 on 02/12/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +44.64% since 10/23/23 | -12.39% since 10/23/23 | +0.30% since 10/23/23 | -13.18% since 10/23/23 | +10.40% since 10/23/23 |
| Low | 19.34 on 11/01/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 41.47 on 02/12/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,426,054 | 99,594,944 | 145,845,984 | 83,357,904 | 103,362,928 |
| Shares Outstanding, K | 50,037 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 520,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -152,100,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -40,730,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.42 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.94 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 04/23/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.52 | 14.42 | 9.93 | 29.34 |